This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Anguita, J.
Right arrow Articles by Fikrig, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anguita, J.
Right arrow Articles by Fikrig, E.

 Previous Article  |  Next Article 

Infect. Immun., 08 1997, 3037-3041, Vol 65, No. 8
Copyright © 1997, American Society for Microbiology

B7-1 and B7-2 monoclonal antibodies modulate the severity of murine Lyme arthritis

J Anguita, R Roth, S Samanta, RJ Gee, SW Barthold, M Mamula and E Fikrig
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8031, USA.

We assessed the role of B7-1 and B7-2 costimulatory molecules on the course of murine Lyme borreliosis because experimental Lyme arthritis is dependent, at least partially, upon the development of the host immune response and these costimulatory molecules have been implicated in CD4+ T-cell differentiation. We demonstrated that Borrelia burgdorferi infection upregulated the surface expression of B7-1 and B7- 2 in macrophages and B7-2 expression in B cells. Anti-B7-2 monoclonal antibody (MAb) or both anti-B7-2 and anti-B7-1 MAbs produced a dose- dependent increase in the severity of Lyme arthritis in C3H/HeN mice. In contrast, the administration of an anti-B7-1 MAb reduced the degree of arthritis. These effects occurred independently of significant alteration in B. burgdorferi-specific immune responses, including splenocyte proliferative responses to B. burgdorferi, B. burgdorferi antibody levels and specificity, and mRNA levels of gamma interferon, interleukin-4 (IL-4), IL-10, and IL-12 in the spleen. These results demonstrate that signaling delivered by B7-1 and B7-2 plays a role in determining the severity of acute murine Lyme arthritis.


This article has been cited by other articles:

  • Brown, C. R., Blaho, V. A., Loiacono, C. M. (2003). Susceptibility to Experimental Lyme Arthritis Correlates with KC and Monocyte Chemoattractant Protein-1 Production in Joints and Requires Neutrophil Recruitment Via CXCR2. J. Immunol. 171: 893-901 [Abstract] [Full Text]  
  • Brown, C. R., Reiner, S. L. (1999). Experimental Lyme Arthritis in the Absence of Interleukin-4 or Gamma Interferon. Infect. Immun. 67: 3329-3333 [Abstract] [Full Text]  
  • Shanafelt, M.-C., Kang, I., Barthold, S. W., Bockenstedt, L. K. (1998). Modulation of Murine Lyme Borreliosis by Interruption of the B7/CD28 T-Cell Costimulatory Pathway. Infect. Immun. 66: 266-271 [Abstract] [Full Text]